NASDAQ:EDSA

Edesa Biotech Stock Insider Trading

etoro logo Buy EDSA
*Your capital is at risk
$5.11
-0.140 (-2.67%)
At Close: Jul 31, 2026

Edesa Biotech Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 2.92M and sold 0 EDSA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 2.92M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
May 29, 2025
Buy
Common Shares
A-Award
Chypyha Joan
Director
Director 11 000
Value: $21.9K
May 29, 2025
Buy
Common Shares
A-Award
Macdonald Sean Arthur
Director
Director 20 001
Value: $39.8K
May 29, 2025
Buy
Common Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 263 200
Value: $523.8K
May 29, 2025
Buy
Common Shares
A-Award
Sistilli Carlo
Director
Director 20 001
Value: $39.8K
May 29, 2025
Buy
Common Shares
A-Award
Olson Charles V
Director
Director 11 000
Value: $21.9K
May 29, 2025
Buy
Common Shares
A-Award
Marshall Patrick
Director
Director 11 000
Value: $21.9K
May 02, 2025
Buy
Common Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 6 392
Value: $15.2K
May 02, 2025
Buy
Common Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 6 392
Value: $15.2K
May 01, 2025
Buy
Common Stock
J-Other
Weiler Peter J.
Officer
Officer 0
Value: $0
May 01, 2025
Buy
Common Stock
J-Other
Weiler Peter J.
Officer
Officer 0
Value: $0
Apr 01, 2025
Buy
Common Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 5 784
Value: $13.4K
Apr 01, 2025
Buy
Common Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 5 784
Value: $13.4K
Mar 03, 2025
Buy
Common Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 6 339
Value: $13.1K
Mar 03, 2025
Buy
Common Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 6 339
Value: $13.1K
Feb 12, 2025
Buy
No securities are beneficially owned
Liu Da David
Director
Director 0
Value: $0
Feb 12, 2025
Buy
No securities are beneficially owned
Liu Da David
Director
Director 0
Value: $0
Feb 12, 2025
Buy
Common Shares
A-Award
Sistilli Carlo
Director
Director 10 416
Value: $20.0K
Feb 12, 2025
Buy
Series B-1 Convertible Preferred Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 100
Value: $2
Feb 12, 2025
Buy
Common Shares
A-Award
Marshall Patrick
Director
Director 41 666
Value: $80.0K
Feb 12, 2025
Buy
Common Shares
A-Award
Marshall Patrick
Director
Director 41 666
Value: $80.0K
Feb 12, 2025
Buy
Series B-1 Convertible Preferred Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 100
Value: $2
Feb 12, 2025
Buy
Common Shares
A-Award
Sistilli Carlo
Director
Director 10 416
Value: $20.0K
Feb 03, 2025
Buy
Common Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 8 264
Value: $16.1K
Feb 03, 2025
Buy
Common Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 8 264
Value: $16.1K
Jan 06, 2025
Buy
Common Shares
A-Award
Nijhawan Pardeep
Chief Executive Officer
CEO / President 8 476
Value: $16.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT EDESA BIOTECH, INC.
Edesa Biotech
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chro...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE